Five things for pharma marketers to know: Thursday, May 25, 2017

Share this content:

1. Fitness trackers reliably capture data about heart rate but often do not accurately capture how many calories a person has burned, according to a study. The study's author, a cardiologist, said patients are increasingly asking their doctors to look at these kinds of data. (NPR)

2. Some health-technology startups are reevaluating their products because of the uncertain political environment. This includes companies developing tools or products for insurers or hospitals facing potential cuts in Medicaid. (WSJ)

3. An FDA advisory committee voted 12-to-4 recommending that the FDA approve Puma Biotechnology's experimental breast cancer drug. The committee said the benefits outweighed the risks but also noted that the extent of the drug's benefit is modest. (Reuters)  

4. GW Pharmaceuticals plans to file its cannabis-derived drug with the FDA this year. The experimental therapy, Epidiolex, would be used as a treatment for severe childhood epilepsy and Dravet and Lennox-Gastaut syndrome, another form of epilepsy. (Reuters)

5. The Congressional Budget Office said if the American Health Care Act, a replacement to the Affordable Care Act, is implemented that 14 million more people would be uninsured next year and 23 more million in 2026. (NYT)

Share this content:
Scroll down to see the next article